We subsequently evaluated TCR activation in co-culture with two HLA-A*02-restricted melanoma cell lines, MALME-3M and SK-MEL-5, which we first engineered to express the dCas9-KRAB-MeCP2 transcriptional repression system. The gene discussed is HLA-A; the disease is melanoma.